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The effect of B27 supplement on promoting in vitro propagation of
Her2/neu-transformed mammary tumorspheres
Yiben Gu1, Jie Fu1, Pang-Kuo Lo1, Shunqi Wang1, Qian Wang2, Hexin Chen1, *
1

Department of Biological Sciences, 2Department of Chemistry and Biochemistry, University of South
Carolina, Columbia, SC 29208, USA
A variety of human solid tumors, including breast cancer, are considered to embrace a hierarchical organization
in which only rare tumor-initiating cancer stem cells are truly responsible for tumor formation. Cultivation of
tumorspheres in non-adherent conditions is widely employed for enriching these putative cancer stem cells in
vitro. However, the absence of a defined culture medium has handicapped further characterization and isolation
of this cell population. In this study, we used mouse mammary tumor virus MMTV-HER2/neu transgenic mice
that mimic the HER2/Neu-positive subtype of human breast cancer as a model system, and cultured primary
tumor cells and tumorspheres from these mice under non-adherent conditions. In addition to essential growth
factors, we found that B27 supplement played an important role in promoting tumorsphere formation and
maintaining cultures through passaging. A tumorsphere-formation assay and measurements of average
tumorsphere size provided insight into the characteristics of the putative breast cancer stem cells.
Tumorspheres were enriched for cancer stem cells through serial passaging, while sphere size was determined
by the innate properties of cancer stem cells and independent of the culture condition. Our study identifies B27
as an essential component of culture medium necessary for sustained propagation and enrichment of breast
cancer stem cells in vitro.
* Corresponding author: Tel: (803)777-2928; E-mail: hchen@biol.sc.edu

Introduction

rates vary greatly depending on factors such as
genetic alterations, stage, metastastic ability
and therapeutic resistance [5].

Solid tumors account for an enormous cancer
burden on society and represent an urgent
therapeutic challenge. Epithelial cancers that
derive from tissues including breast, lung,
colon, prostate, pancreas, brain and ovary
constitute approximately 80% of all cancers [1].
Breast cancer is the predominant malignancy in
women, resulting in more than 40,000 fatalities
annually in the United States alone and 10
times that number worldwide [2, 3]. Breast
cancer arises from breast tissue, most
commonly from inner lining of lactiferous ducts
(ductal carcinoma) or the lactating lobules
(lobular carcinoma) [4]. Different subtypes of
breast cancer have been identified, and survival

Approximately 25~30% of human breast
cancers have an amplification of the Her2/neu
gene. The Her2/neu proto-oncogene encodes a
transmembrane tyrosine kinase receptor that is
a member of the epidermal growth factor
receptor (EGFR) family [5-7]. This receptor is
normally activated by growth factors that cause
cells proliferation and division, and switched
“off” in the absence of such growth factors.
Overproduction of Her2/neu protein, which acts
a key activator of proliferative signaling
networks, leads to uncontrolled cell
proliferation associated with an aggressive form
7
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of breast cancer [8]. Her2/neu-positive breast
cancer tends to be particularly invasive and is
often associated with tumor relapse, enhanced
metastasis, induced chemotherapy resistance,
poorer prognosis and reduced overall survival
rates [5, 9]. Her2/neu-positive breast cancer is
also resistant to hormonal therapy [8].
Monoclonal antibodies such as trastuzumab
(Herceptin) have been used to target Her2/neu,
usually in combination with chemotherapy, to
improve survival rate for this patient population
[7, 9]. However, this therapy is expensive and
not tolerated among all patients. This demands
prospective insights into the underlying
mechanisms involved in Her2/neu-positive
breast cancer, which will contribute to the
development of improved therapies to
eradicate this malignancy.

[10, 13]. A few additional properties are also
shared by normal stem cells and cancer stem
cells, which include the ability to migrate, the
activation of membrane transporter activity,
and resistance to apoptosis and chemotherapy
[13]. The growth of cancer stem cells requires
alterations in vital metabolic and signaling
pathways and cell cycle progression that lead to
the emergence of tumorigenic phenotypes [3,
14, 15]. As suggested in this theory, normal
stem cells are targets of mutations that convert
normal self-renewal potential into neoplastic
engines, and only these transformed stem cells
are capable of launching tumor formation, and
comprise a tiny fraction of the vast tumor mass
[11, 15-18].
There is growing evidence revealing the
existence of cancer stem cells in a variety of
human cancers, including leukemia [19] and
several solid tumors such as breast [2, 20], brain
[21, 22], melanoma [23], prostate [24], colon
[25, 26], pancreatic [27] and lung cancer [28]. A
number of methods have been developed for
identifying putative cancer stem cells. As far as
is known, cancer stem cells resemble normal
stem cells in their ability to grow through selfrenewal as non-adherent spherical clusters,
known as tumorspheres, when an adherent
substratum is not provided in the culture
system [21, 29]. Therefore, the most widely
used method is to grow primary tumor cells in
serum-free non-adherent conditions, in which
only the small fraction of tumor-initiating
stem/progenitor cells within the tumor mass
can survive and form tumorspheres in
suspension [13, 20, 29]. In many cases, the
tumorsphere can only survive for a few
passages and gradually dies [26, 29]. In this
study, we cultured tumorspheres from MMTVHer2/Neu transgenic mouse mammary tumors
and found that addition of one supplement,

To accomplish this goal, it is necessary to
address the question of the cellular origins of
solid tumors. Two major models have emerged
over decades of cancer research. The stochastic
model predicts that transformation is a result of
random mutation and subsequent clonal
selection [10]. In this model, any cell can
accumulate neoplastic mutations and transform
into a cancer cell, and any cancer cell has a
similar potential for unlimited proliferation and
tumor generation [10-12]. In contrast, the
cancer stem cell theory views tumor as an
aberrant organ, to which the principles of stem
cell biology can be applied. In a similar way to
normal tissues that are derived from somatic
stem cells, the tumor is organized in a hierarchy
that is initiated by tumorigenic cancer cells, or
termed as cancer stem cells. The cancer stem
cells acquire the capacity for extensive
proliferation through accumulated mutations,
and have the ability to initiate a tumor in
immune-compromised mice that recapitulates
the original heterogeneity of the patient tumor
8
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B27, to the culture medium, can dramatically
increase sphere-forming efficiency and sustain
the propagation of tumorspheres for more than
20 passages. This finding will help to relieve the
limitation of expanding cancer stem cells in
vitro.

medium (Gibco), which was supplemented with
20 ng/ml epidermal growth factor (EGF, Sigma),
10 ng/ml basic fibroblast growth factor (bFGF,
Sigma), 0.4% bovine serum albumin (BSA,
Sigma), and 5 μg/ml insulin (Sigma). 1×B27
supplement (Gibco) was added to the
treatment group to investigate its effect on
tumorsphere formation. Cells were incubated in
a humidified atmosphere with 5% CO2 at 37°C
for 6 days, and collected by gentle
centrifugation. The pelleted cells were
enzymatically dissociated with accutase
(Innovative Cell Technologies) for 10 minutes at
room temperature, and mechanically dispersed
by gently pipetting through a 23-gauge sterile
needle. Single-cell suspensions were plated at
the same density and culture conditions as
described above, to generate the second
generation of tumorspheres, and so forth.

Materials and Methods
Isolation of cancer cells from MMTV-Neu
transgenic mouse mammary tumors
Spontaneous mammary tumors that developed
from MMTV-Neu transgenic mice were
harvested, physically separated from connective
and fat tissues, and transferred into DMEM/F12
medium (Gibco). Tumor tissues were minced
into small pieces with a sterilized scalpel, and
digested in DMEM/F12 medium with 1.5 mg/ml
collagenase (Worthington) and 20 μg/ml
hyaluronidase (MP Biomedicals) with agitation
at 200 rpm for 2 hours at 37℃. The pellet was
collected by centrifugation at 1200 rpm for 5
min, and incubated with 0.64% NH4Cl (Stem Cell
Technologies) for 3 min to lyse red blood cells.
The suspension was centrifuged at 1200 rpm for
5 min and the supernatant was discarded. The
pellet was resuspended in DMEM/F12 medium
and passed through a 40 μm strainer (PALL
Corporation) to collect single cells, which were
in turn transferred and maintained in
Dulbecco’s modified Eagle’s medium (DMEM,
Gibco) with 10% fetal-bovine serum (FBS, SAFC
Biosciences) and 10 μg/ml insulin (Sigma) as
primary tumor cells, which were named as
parental cells.

RNA purification and PCR amplification
Total RNA was extracted from parental cells and
tumorspheres using TRIzol Reagent (Invitrogen)
according to the manufacturer’s instructions. 1
μg of total RNA was used for the reverse
transcription assay to generate cDNA using MMLV reverse transcriptase (Invitrogen). 1 μl of
cDNA was used for a single PCR reaction to
determine the expression levels of cell
differentiation markers and stem cell markers.
The following genes of interest were selected
and tested by regular PCR: Klf4, Oct4, Sox2,
Nanog, keratin 8, keratin 14, and keratin 18.
Quantitative real-time PCR analysis
The quantitative RT-PCR was performed using
the fluorescent dye SYBR Green Master Mix
(Qiagen, CA) following standard protocols on an
ABI PRISM 7300 sequence detection system
(Applied Biosystems, CA). The data were first
analyzed using the Sequence Detector Software
SDS 2.0 (Applied Biosystems). Results were

In vitro propagation of tumor-initiating
mammospheres
Cells harvested from spontaneous tumors were
counted and then plated in petri dishes at a
constant density of 40,000 viable cells per ml.
Cells were grown in serum-free DMEM/F12
9
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calculated and normalized relative to the
GAPDH control by using the Microsoft Excel
program. The relative expression values were
calculated relative to GAPDH by using the 2-ΔCT
method [40]. The data shown here represent
the average of three independent experiments.

ability of MMTV-Neu tumor cells to form
tumorspheres, parental cells were collected and
plated in serum-free DMEM/F12 medium that
contained EGF, bFGF, BSA, insulin and B27
supplement. After six days of cultutre, the
majority of the cells died, however a small
fraction of cells survived and formed spherical
clusters in suspension (tumorspheres) (Fig. 1B),
which implied the existence of putative breast
cancer stem cells that possessed stem cell-like
self-renewal properties.

Tumorsphere-forming efficiency assay and size
characterization
Tumorspheres were dissociated to single cells
as described above, and plated in ultra-low
attachment 96-well plate (Costar). 1000, 500,
200, 100 and 50 cells were plated in 100μl of
serum-free medium per well, respectively in
triplicate. The number of spheres formed in
each well was determined after 6 days.
Tumorspheres from every passage were
dissociated and assayed for tumorsphereforming efficiency. Meanwhile, tumorsphere
size, defined as number of cells per sphere, was
assessed for tumorspheres at every passage.

Candidate stem cell marker genes were
overexpressed in tumorspheres
We examined the expression levels of a few
known molecular markers of cancer stem cells
in tumorspheres in relative to parental cells.
This showed that putative stem cell markers,
such as Oct4, Sox2, Klf4, Stem Cell Antigen-1
(Sca1) and Aldehyde dehydrogenase 1 (Aldh1)
were overexpressed in tumorspheres, and
differentiation markers for luminal epithelial
cells like keratin 18 and myoepithelial cells like
smooth
muscle
actin
(SMA)
were
underexpressed in tumorspheres, compared
with parental cells (Fig. 2). The expression
profile of these marker genes suggests the
presence of cancer stem cell population within
the tumorspheres at a molecular level. Note
that cell differentiation markers were not
always underexpressed in tumorspheres
relative to parental cells. The reason for this
possibly lies in the presence of cancer stem cellderived progeny within the tumorspheres that
entered and stayed at various stages of
differentiation. Stem/progenitor cells only
constitute a tiny fraction of the heterogeneous
cellular composition of tumorspheres. Hence
the majority of cells at more differentiated
stages was sufficient to give a high expression
level of cell differentiation markers which
almost equaled that of parental cells.

Results
Generation of mammary tumorspheres in nonadherent conditions
Spontaneous
tumors
from
MMTV-Neu
transgenic mice were dissociated to single cells
and transferred into tissue culture flasks in
DMEM medium with serum for cultivating
primary tumor cells. After subculturing the cells
for a few passages with enzymatic treatment to
simultaneously remove fibroblasts and other
non-tumor cells, primary tumor cells (named in
this study as parental cells), formed an
adherent monolayer with uniform morphology
covering the bottom of a tissue culture flask
(Fig. 1A). Tumor-initiating cells, as far as is
known, resemble stem cells in their ability to
grow through self-renewal as non-adherent
spherical clusters, known as tumorspheres, with
a non-adherent substratum [21, 29]. To test the
10
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Figure 1. Culture of tumor cells isolated from spontaneous tumor tissues of MMTV-Her2/neu transgenic mice at different conditions. (A)
Primary tumor cells were cultured in DMEM containing 10% FBS, exhibiting an epithelial-like morphology. (B) Mammary tumorspheres were
grown in non-adherent suspension medium, presenting smooth-edged spherical phenotypes. Original magnification in A and B: ×100.

Figure 2. Gene profiling of stem cell markers and cell differentiation markers in monolayer (ML) cells and tumorspheres (TS). (A) RT-PCR
analysis was performed to obtain the gene expression profiles in parental cells and tumorspheres. (B) Real-time PCR was performed to evaluate
the relative expression levels of stem cell and differentiation marker genes in parental cells and tumorspheres. Putative stem cell markers,
Oct4, Sox2, Klf4, Nanog, Stem Cell Antigen-1 (Sca1) and Aldehyde dehydrogenase 1 (Aldh1) were overexpressed in tumorspheres (TS), and cell
differentiation markers, Keratin 8, Keratin 14, Keratin 18 and smooth muscle actin (SMA), were overexpressed in parental cells (ML).
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Figure 3. Optical microscopy for tumorspheres from serial cultivation in the suspension medium with or without the presence of B27
supplement. Morphological differences were visualized between tumorspheres maintained in two types of medium. As for +B27 medium, no
significant morphological change was discerned over serial passaging. Original magnification: ×100.

B27 supplement is crucial for serially
maintaining tumorspheres in vitro
Initially, we chose the simplest recipe of
tumorsphere propagation medium containing
only EGF and bFGF as essential growth factors
and BSA and insulin as supplemental
components [29, 30]. Although tumorspheres
grew successfully in this medium for the first
few
passages,
serial
subcultures
of
tumorspheres eventually failed. Bubble-like
hollow
aggregates
replaced
normal
tumorspheres after four or five passages, and
repeated tests reproduced the same
phenomenon. By comparing a large number of
potential nutrients, we assumed that the

addition of B27 supplement was essential and
could replenish what was required for serial
generation of stem cells (self-renewal) but
missing in the previous medium [5, 20, 31-35].
Accordingly, tumorspheres were successfully
maintained for more than 20 passages in B27containing medium. In addition, the
morphology of tumorspheres cultured in B27free medium seemed to lose smoothness and
gain roughness because of adherence of cells to
the spherical edges during serial passaging (Fig.
3). The strong contrast between the two culture
conditions implied that B27 is playing an
important role in maintaining and promoting
tumorsphere propagation in vitro. To test
12
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Figure 4. Tumorsphere culture of MCF7 breast cancer cells in the suspension medium with or without the presence of B27 supplement. (A)
Morphological differences were visualized between tumorspheres maintained in two types of medium. As for +B27 medium, no significant
morphological change was discerned over serial passaging. Original magnification: ×100. Scale bars represent 100µm. (B) Tumorsphere-forming
efficiency assay. One hundred cells were seeded into ultra-low attachment 96-well plate. The sphere numbers are counted after 6 days. The Y
axis shows the sphere-forming efficiency which represents the average number of tumorspheres per one hundred seeded cells.

whether that B27 has the similar effects on
sphere formation of other cells, we cultured
another human breast cancer cell line MCF7 in
the presence and absence of B27 supplement.
As expected, MCF7 cells in presence of B27
formed typical tumorsphere with higher
efficiency (5.375% +B27 medium vs. 3.25% -B27
medium). In contrast, cells cultured in the B27free medium formed atypical tumorspheres
which were more like cell aggregates (Fig. 4).

supplement. In this assay, tumorsphere-forming
efficiency reflected the percentage of cells that
were capable of forming tumorspheres, in other
words, the proportion of cancer stem cells. This
experiment clearly showed that the efficiency
of tumorsphere-formation gradually increased
in the presence of B27 (Fig. 5). This suggested
that over time, an increasing number of cells
had obtained the ability to self-renew and form
tumorspheres, reflecting an enrichment of
cancer stem cells. However, for tumorspheres
maintained in B27-free medium, tumorsphereforming efficiency rose slightly for the first
three passages, resembling the trend observed
in B27-containing medium, but dropped at the
fourth generation when bubble-like aggregates
began to replace typical spheres (Fig. 5), until
tumorspheres were no longer observed after
the fifth generation. This result supports our
earlier observations that B27-free medium
failed to maintain tumorsphere formation
beyond four or five passages. Hence, B27 was

Cancer stem cells were enriched through serial
propagation
In order to passage tumorspheres, they were
enzymatically and mechanically dissociated into
a single cell suspension, and replated at a
constant density of 40,000 viable cells per ml.
Tumorsphere-forming efficiency was evaluated
using an ultra-low attachment 96-well plate as
described in materials and methods, and
performed with tumorspheres from every
passage in the presence and absence of B27
13
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Figure 5. Tumorsphere-forming efficiency assay. Cells were seeded into ultra-low attachment 96-well plate. Five different cell densities were
tested for +B27 and –B27 medium, respectively. Indicated numbers of the perpendicular axis showed average number of tumorspheres per well
for a given starting cell density.

essential for promoting tumorsphere-forming
efficiency in vitro as well as maintaining serial
propagation through which cancer stem cells
were enriched.

Discussions
The cancer stem cell hypothesis was proposed
to resolve the question of cellular origins of
malignancy, and to explain the observation that
only a small proportion of cells within a tumor
were tumorigenic [1, 10, 16]. Cancer stem cells,
representing only a small fraction of cells within
the bulk of tumor, have properties that render
them capable of initiating a tumor, in contrast
to the non-tumorigenic majority of cells [10, 15,
18]. Although cancer stem cells have not yet
been isolated and fully characterized, there is a
body of growing evidence revealing the
existence of this population in a variety of
human cancers [19-28]. The investigation and
characterization of cancer stem cells has
important implications for understanding
cancer biology and in the development of
efficient therapies [13, 20].

Tumorsphere size was dependent on the
innate properties of cancer stem cells
Our data showed that B27-containing medium
supported the serial culture of tumorspheres.
We then grew tumorspheres for multiple
passages under these conditions and measured
the size of individual tumorspheres, by counting
the number of cells per tumorsphere.
Surprisingly, the average tumorsphere size did
not exhibit a dramatic difference over serial
passaging (Fig. 6). We therefore concluded that
tumorsphere phenotypes such as morphology
and size were determined by the innate
properties of the cancer stem cells, rather than
the number of cancer stem cells.

14
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Figure 6. Characterization of average tumorsphere size. The tumorspheres cultured in +B27 and –B27 medium were collected and dissociated
for size evaluation. The range of average size was 170~193 cells per sphere.

When primary cancer cells from the mouse
mammary tumors in our study were cultivated
on a solid substratum in the presence of serumcontaining
medium,
cell
underwent
differentiation induced by environmental
stimuli. A suitable system was urgently needed
to maintain the cancer stem cells in an
undifferentiated state, to allow serial passaging
and propagation in culture. As cancer stem cells
were speculated to resemble their non-mutated
counterparts in the ability of forming spheres in
non-adherent
serum-free
condition,
a
prospective method of propagating/enriching
solid cancer stem cells in vitro was developed
[5]. Major advances were achieved when an
undifferentiated population of neural cells
could be grown in suspension without losing
multipotential differentiation capacity, and
these cells formed non-adherent spherical

clusters, termed as neurospheres, and
contained 4~20% of stem cells [36, 37]. This
method was instrumental in cancer stem cell
research for various human malignancies, and
was also employed in the study of breast cancer
[2, 20, 29]. We adopted the same method, and
have successfully grown tumorspheres from
primary tumor cells in an anchorageindependent suspension in the presence of
suitable growth factors (EGF and bFGF). At the
molecular level, putative stem cell markers
were overexpressed in these mammary
tumorspheres, showing a molecular signature
of their stem cell-like properties.
However, the absence of suitable defined
systems
to
maintain
cells
in
the
undifferentiated state impeded further progress
in the isolation and characterization of the
15

Journal of Biotech Research [ISSN: 1944-3285]

2011; 3:7-18

cancer stem cells, rendering this population
elusive [13, 20, 38]. It is important to initially
establish a reliable in vitro system of
maintaining the scarce cancer stem cells. In our
study of HER2/Neu-transformed breast cancer
stem cells, we found the powerful effect of B27
supplement in promoting tumorsphere
formation and maintaining serial propagation,
compared with the B27-free medium. The
advantage of B27 supplement was clearly
apparent.
Firstly,
serial
cultures
of
tumorspheres were achieved, allowing for a
constant source of tumorspheres for the longterm study of breast cancer stem cells, owing to
the role of B27 in increased survival of
tumorspheres [20, 34, 39] and prevention of
adherences [35]. Secondly, a tumorsphereforming efficiency assay exhibited the role of
B27 supplement in improving the tumorsphereforming efficiency over serial passaging.
Assessment of tumorsphere-forming efficiency
revealed the enrichment of the cells capable of
self-renewing and forming tumorspheres. The
high productivity of “higher” passages of
tumorspheres helps to save time and the
investment
in
expensive
tumorsphere
cultivation. One of the potential pitfalls is that
the tumorspheres are heterogeneous in nature.
Despite the increase in sphere-forming
efficiency, only a relatively small percentage of
cells with each sphere hold the sphere-forming
capacity. In addition, not all sphere-forming
cells fulfill the criteria of being cancer stem
cells. The heterogeneity of tumorsphere in
cellular origin and composition makes it
possible that the percentage of cancer stem
cells may decrease after extended numbers of
passages in vitro, e.g. the cancer stem cells may
be outnumbered by cancer progenitor cells with
capacity to form sphere. But the total cancer
stem cells population will expand through self
renewal with continuously passaging of

tumorspheres. Lastly, B27 also seemed to be
favorable in preserving adequate viability of
frozen tumorspheres. Tumorspheres stored at 80ºC freezer showed a higher recovery rate in
freezing medium that contained B27
supplement (data not shown). Despite the
unknown effects of diverse components, B27
supplement, it is clearly an essential part of the
culture medium necessary for sustained in vitro
tumorsphere propagation and the study of
cancer stem cells.
Conclusions
We grew primary tumor cells and tumorspheres
out of mammary tumor tissue harvested from
MMTV-Neu transgenic mice. In the process of
characterization of mammary tumorspheres,
we found that B27 supplement, in addition to
essential growth factors, played an important
role in promoting tumorsphere formation and
sustaining serial cultures, compared with the
counterparts maintained in B27-free medium. A
tumorsphere-formation assay revealed the
enrichment of breast cancer stem cells in vitro
through serial passaging. The average
tumorsphere size was, however, independent
of the culture condition and inferred to be
determined only by the innate properties of
cancer stem cells. Yet the mechanism remains
unknown, our study identifies that B27
supplement is necessary for sustained
propagation and enrichment of breast cancer
stem cells in vitro.
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